Schond Greenway
Net worth: 274 191 $ as of 30/04/2024
Career history of Schond Greenway
Former positions of Schond Greenway
Companies | Position | Start | End |
---|---|---|---|
MIND MEDICINE (MINDMED) INC. | Director of Finance/CFO | 23/05/2022 | 03/05/2024 |
AVALO THERAPEUTICS, INC. | Director of Finance/CFO | 01/03/2021 | 14/02/2022 |
Treasurer | 01/03/2021 | 14/02/2022 | |
MESOBLAST LIMITED | Investor Relations Contact | 01/01/2016 | 01/02/2021 |
HALOZYME THERAPEUTICS, INC. | Investor Relations Contact | 01/11/2013 | 01/01/2016 |
DURECT CORPORATION | Public Communications Contact | - | - |
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Corporate Officer/Principal | - | - |
Training of Schond Greenway
Florida A&M University | Undergraduate Degree |
University of Virginia Darden School of Business | Masters Business Admin |
Statistics
International
United States | 7 |
Australia | 2 |
Canada | 2 |
Operational
Investor Relations Contact | 2 |
Director of Finance/CFO | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 5 |
---|---|
MESOBLAST LIMITED | Health Technology |
AVALO THERAPEUTICS, INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
DURECT CORPORATION | Health Technology |
MIND MEDICINE (MINDMED) INC. | Health Technology |
Private companies | 1 |
---|---|
Barclays Capital, Inc.
Barclays Capital, Inc. Investment Banks/BrokersFinance Barclays Capital, Inc. is a registered broker/dealer headquartered in New York City. The firm was founded in 1997 and is a subsidiary of Barclays Group US, Inc., ultimately owned by Barclays plc (LON: BARC) in Great Britain. Barclays Capital provides large corporate, government and institutional clients a full spectrum of prime brokerage services which includes equities and fixed income financing, OTC Clearing, Futures and Foreign Exchange Prime Brokerage and access to industry insights and analytics from their Strategic Consulting team. | Finance |
- Stock Market
- Insiders
- Schond Greenway
- Experience